Neurological Disorder Diagnostics Market to Grow with a CAGR of 7.45% through 2029
Increasing Prevalence of Neurological Disorders and Growing Emphasis on
Early Diagnosis and Disease Management are expected to drive the Global Neurological
Disorder Diagnostics Market growth in the forecast period, 2025-2029
According to TechSci Research report, “Neurological
Disorder Diagnostics Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global Neurological
Disorder Diagnostics Market stood at USD 9.45 billion in 2023 and is
anticipated to grow with a CAGR of 7.45% in the forecast period through 2029.
Rising global healthcare expenditure, alongside
increased funding for research into neurological disorders, supports the
development and commercialization of advanced diagnostic technologies.
Pharmaceutical companies, diagnostic laboratories, and research institutions
are investing significantly in research and development (R&D) to introduce
novel biomarkers, imaging modalities, and molecular diagnostic assays, thereby
expanding the market.
Government initiatives aimed at enhancing healthcare
infrastructure and streamlining approval processes for diagnostic devices are
accelerating market entry and adoption. This regulatory support stimulates
innovation and encourages investments in neurology diagnostics.
Growing awareness among healthcare professionals,
patients, and caregivers regarding the benefits of early diagnosis and
personalized treatment options for neurological disorders is driving market
demand. Patient advocacy groups play a crucial role in advocating for improved
diagnostic access, increased research funding, and policy reforms, positively
influencing market dynamics.
There is a noticeable shift towards early diagnosis
and proactive disease management in neurology. Early detection through screening programs and advanced diagnostic tools not only enhances patient outcomes but also reduces healthcare costs associated with disease progression
and complications. This emphasis on early intervention prompts healthcare
providers and policymakers to invest in cutting-edge diagnostic solutions,
thereby fostering market growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Neurological Disorder Diagnostics Market”
The Global Neurological Disorder Diagnostics Market is
segmented into product, disease indication, end user, regional distribution,
and company.
Based on its end user, the hospitals and specialty
clinics segment has emerged as the predominant market leader, Hospitals and
specialty clinics typically have access to advanced diagnostic equipment and
facilities required for accurate neurological assessments. This includes
neuroimaging technologies such as MRI (Magnetic Resonance Imaging), CT
(Computed Tomography), PET (Positron Emission Tomography), and specialized labs
equipped for genetic testing, biomarker analysis, and electrophysiological
tests (EEG, EMG). These capabilities enable comprehensive evaluation and
diagnosis of a wide range of neurological disorders, from stroke and epilepsy
to neurodegenerative diseases like Alzheimer's and Parkinson's. Neurological
disorders often require a multidisciplinary approach involving neurologists,
neurosurgeons, neuroradiologists, and other specialists. Hospitals and
specialty clinics provide a collaborative environment where experts from
various disciplines can collaborate to diagnose complex neurological conditions
accurately. This integrated approach ensures that patients receive
comprehensive care, from initial diagnosis through to treatment planning and
management. Hospitals are equipped to handle acute neurological emergencies and
provide critical care interventions such as neurointensive care units (NICUs)
and neurorehabilitation services. Specialty clinics, focusing exclusively on
neurology or specific neurological conditions, offer specialized outpatient
diagnostic services and ongoing management for chronic neurological disorders.
These facilities play a crucial role in improving patient outcomes and quality
of life by providing timely access to specialized care and treatment options.
The Europe region is experiencing rapid market growth.
Europe boasts a well-established healthcare infrastructure characterized by
sophisticated healthcare systems, modern medical facilities, and high
accessibility to advanced diagnostic technologies. This infrastructure supports
comprehensive neurological diagnostics, including neuroimaging (MRI, CT, PET
scans), genetic testing, and specialized laboratory diagnostics, ensuring
accurate and timely diagnosis of neurological disorders. European countries prioritize investment in medical
research and innovation, particularly in the field of neurology. Academic
institutions, research centers, and pharmaceutical companies collaborate
extensively to develop and validate novel diagnostic technologies and
biomarkers for neurological disorders. This collaborative research environment
fosters innovation, accelerates market entry for new diagnostic solutions, and
drives market growth in neurology diagnostics. Europe maintains stringent yet
supportive regulatory frameworks for medical devices and diagnostic tests. The
European Medicines Agency (EMA) and national regulatory authorities ensure
rigorous evaluation and approval processes, safeguarding patient safety and
fostering confidence in new diagnostic technologies. The streamlined regulatory
pathways facilitate market entry for innovative neurology diagnostics,
attracting investments from global diagnostic companies and promoting market
expansion.
Major companies operating in Global Neurological
Disorder Diagnostics Market are:
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Esaote SPA
- NeuroLogica Corp.
- Masimo Corp
- Neusoft Corporation
- CANON MEDICAL SYSTEMS CORPORATION
- Abbott Laboratories Inc
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“Global Neurological Disorder Diagnostics Market is
poised for robust growth driven by advancing technologies, increasing
healthcare investments, and a growing emphasis on early detection and
personalized treatment. Key regions such as Europe are leading the way with
their sophisticated healthcare infrastructure and supportive regulatory
environments, while innovations in diagnostics continue to enhance patient
outcomes and expand market opportunities globally. As the market evolves,
stakeholders across healthcare, research, and regulatory sectors are expected
to play pivotal roles in shaping the future landscape of neurology diagnostics,
ensuring improved accessibility, accuracy, and efficacy in neurological care”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Neurological Disorder Diagnostics Market –
Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By
Product (Imaging, In Vitro Diagnostics), By Disease Indication (Genetic
Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic
Syndrome, Paraproteinemic Neuropathies), By End User (Hospitals and Specialty
Clinics, Diagnostic Centres, Ambulatory Care Centers), By Region, Competition, 2019-2029F”, has evaluated the future growth potential of Global
Neurological Disorder Diagnostics Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Neurological Disorder Diagnostics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com